Mubadala has a long-standing presence in North America. In New York, our team of investment professionals invest across a range of sectors and asset classes. We partner with leading institutions to drive value creation that results in transformational growth and has a tangible and positive impact on society.

Mubadala Investment Company — a sovereign investor — manages a diverse portfolio of assets and investments in the United Arab Emirates and abroad, to generate sustainable financial returns for its shareholder, the Government of Abu Dhabi.

Mubadala Investment Company is a sovereign investor managing a diverse portfolio of assets and investments in the United Arab Emirates and internationally, to generate sustainable financial returns.

Mubadala is a global investment company with a mandate to create sustainable financial returns for Abu Dhabi. We are a sovereign investor with an entrepreneurial mindset; we create value by leveraging our talent, our shareholder, our portfolio diversity, and our …

Explore the Interactive Portfolio to know more about Mubadala's global presence, investments and countries of operation.

Mubadala's business is structured around global business platforms that together encompass our interests across more than 50 countries. These platforms allow us to scale and manage our portfolio for growth while maintaining the highest international standards of governance and …

Most recent financial information and activities, including reports on both Mubadala Development Company and IPIC.

Since entering China in 2015, Mubadala has cultivated a presence of experienced professionals driving strategic investments across multiple sectors and asset classes to foster value creation and growth.

Mubadala benefits from the long-term support of its sole shareholder, the Government of Abu Dhabi, as we work to achieve our commercial goals while operating with the highest levels of integrity.

Aug 26, 2024 · Mubadala Investment Company (“Mubadala”), the Abu Dhabi based global investment company announced today that in partnership with CBC Group, Asia's largest healthcare-dedicated asset management group, it has acquired 100% ownership in the carve-out of UCB Pharma’s mature business in China.